This Specialty Fats Stock Rises 49% in 6 Months: Cocoa and Shea Demand Keeps the Rally Alive
- September 24, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Manorama Industries share price climbed from around Rs 1,265 on 24 March 2026 to about Rs 1,885 on 24 September 2026, a gain of roughly 49% in six months.
Quick Answer
Yes, this specialty fats stock has clearly rallied, rising approximately 49% over the past six months on the back of record quarterly revenue, expanding EBITDA margins and a growing export order book. The move is backed by real earnings growth rather than a split or bonus, since the company’s last stock split happened back in March 2024, well outside this window. Investors are responding to capacity additions and new geographies such as Chad and Burkina Faso that support future volume growth. The stock still trades well below its 52-week high, so the rally has not gone unchecked.
A specialty fats stock catering to the global chocolate, cosmetics and pharmaceutical industries has quietly become one of the stronger performers on Indian exchanges this year. Over the past six months the stock has gained close to 49%, moving from roughly Rs 1,265 in late March 2026 to nearly Rs 1,885 by late September 2026, even after a sharp pullback from its 52-week high.
That specialty fats stock belongs to Manorama Industries Ltd, a Raipur-based manufacturer of cocoa butter alternatives, cocoa butter equivalents and shea and mango butter-based ingredients used by global chocolate, cosmetics and pharma companies. The company counts Ferrero, Mondelez, Mars, Hershey, Nestle, Barry Callebaut, L’Oreal, The Body Shop and Lush among its customers across more than 39 countries, and roughly 60% of its revenue still comes from exports.
Click Here – Get Free Investment Predictions
How Has This Specialty Fats Stock Performed Over Different Periods?
The Manorama Industries share price has been one of the more consistent small-cap movers of 2026, though the ride has not been in a straight line. After touching a 52-week high near Rs 2,150 in September 2026, this specialty fats stock corrected roughly 12% in the space of two weeks, a reminder that a specialty fats stock with a market cap of about Rs 12,164 crore and a price-to-earnings ratio well above the industry average can swing quickly on profit booking. Even after that pullback, anyone who bought this specialty fats stock six months ago is sitting on a healthy gain, and the stock remains far above where it traded through most of late 2025 and early 2026.
| Period | Price Return |
|---|---|
| 6 Months (24 Mar 2026 to 24 Sep 2026) | approximately 49% |
| 1 Month | approximately -5% |
| 52-Week High to Current | approximately -12% off high |
What stands out about this specialty fats stock is that the six-month gain has come with a genuine earnings upgrade cycle rather than pure speculation. Trading volumes have picked up sharply on results days, which suggests that a wider set of investors is now paying attention to this specialty fats stock than was the case a year ago, when it traded as a relatively obscure small-cap name outside most screens.
Why Is This Specialty Fats Stock Rising So Fast?
The rally in this specialty fats stock is being driven by genuine operating momentum rather than sentiment alone. Manorama Industries reported record quarterly revenue in June 2026 and again flagged strong growth in its August 2026 results, with margins expanding alongside volumes, which is the combination that tends to re-rate a small-cap ingredient maker. At least three dated, company-specific developments explain why this specialty fats stock has outperformed the broader small-cap index over the past six months.
Record June Quarter for This Specialty Fats Stock: Strong Q1 FY27 Print on 14 August 2026
Manorama Industries posted its June 2026 quarter (Q1 FY27) results on 14 August 2026, with revenue of approximately Rs 420 crore, up close to 39.5% year on year and crossing Rs 400 crore for the first time in a single quarter. EBITDA margin expanded by about 49 basis points to roughly 26.3% while net profit margin widened by around 326 basis points to near 19.5%, and net profit rose to about Rs 78.7 crore against roughly Rs 47 crore a year earlier. The company said 85% of the revenue increase was volume-driven, which supports the idea that this specialty fats stock is being repriced on demand, not just on price hikes.
Capacity Debottlenecking Behind This Specialty Fats Stock: A Rs 460 Crore Expansion Plan
Alongside the results, management laid out a capacity roadmap that investors in this specialty fats stock have latched onto. Existing fractionation capacity is being debottlenecked from 47,500 tonnes per annum to 52,000 tonnes per annum through a Rs 5-6 crore investment targeted for completion by the December 2026 quarter, while a new 75,000 tonnes per annum Fractionation Plant-3 and an additional 300 tonnes per day of refining capacity are planned as part of a broader Rs 460 crore capital expenditure programme spread over the next two to three years.
New Sourcing Geographies for This Specialty Fats Stock: Chad and Burkina Faso
Manorama Industries has also been expanding upstream, incorporating a subsidiary in Chad and acquiring around 10 hectares of land in Burkina Faso for a new shea processing facility, an investment pegged at roughly Rs 120-130 crore. The company achieved first commercial production through a Brazil partnership in the December 2025 quarter as well, and this raw-material diversification is a key reason analysts covering this specialty fats stock expect margins to stay resilient even as volumes scale up.
Check the Univest Screener for Live Fundamentals of High-Return Stocks
Manorama Industries Quarterly and Yearly Financials
The Manorama Industries share price move behind this specialty fats stock is backed by a clean earnings trajectory. Quarterly revenue has risen in four of the last five quarters, from about Rs 295 crore in June 2025 to about Rs 420 crore in June 2026, while net profit nearly doubled in that same stretch, aided by better absorption of fixed costs as fractionation and refining volumes climbed.
| Quarter | Revenue (Rs Cr) | EBITDA (Rs Cr) | Net Profit (Rs Cr) | Net Margin |
|---|---|---|---|---|
| Jun 2025 | 295.3 | 80.5 | 46.9 | 16.2% |
| Sep 2025 | 324.0 | 88.3 | 54.9 | 17.0% |
| Dec 2025 | 374.1 | 113.7 | 72.3 | 19.9% |
| Mar 2026 | 384.3 | 90.4 | 52.5 | 13.4% |
| Jun 2026 | 420.2 | 122.4 | 78.7 | 19.5% |
On a full-year basis, revenue grew from about Rs 792 crore in FY2025 to roughly Rs 1,377 crore in FY2026, while net profit more than doubled from about Rs 110 crore to around Rs 225 crore. Return on equity stands at approximately 33% and the debt-to-equity ratio is a moderate 0.52, which gives this specialty fats stock some headroom to fund its ongoing capex without stretching the balance sheet. Diluted earnings per share rose from about Rs 18.4 in FY2025 to roughly Rs 37.7 in FY2026, and the trailing twelve-month EPS of around Rs 40.9 is a big part of why this specialty fats stock has been able to sustain a rich price-to-earnings multiple without looking disconnected from its underlying profit growth.
Who Owns This Specialty Fats Stock Today?
Promoter holding in this specialty fats stock has stayed steady at approximately 54.3% through the first half of 2026, after having declined gradually from levels above 57% in 2024. Institutional ownership remains modest but has been rising, which is typical for a small-cap ingredient exporter that is only beginning to appear on more fund screens. A handful of domestic mutual fund schemes have taken small positions in this specialty fats stock over the past year, and that incremental buying, even at low single-digit percentages of holding, has added a fresh layer of demand alongside retail participation.
| Category | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Promoters | 54.32% | 54.32% | 54.32% | 54.32% |
| FIIs | 2.52% | 2.71% | 2.89% | 3.22% |
| DIIs | 4.45% | 3.61% | 3.00% | 2.63% |
| Public | 38.71% | 39.36% | 39.78% | 39.83% |
What Are the Risks Behind This Specialty Fats Stock?
The biggest risk for anyone buying this specialty fats stock today is valuation. At a price-to-earnings ratio of about 47 times, well above the industry average of roughly 35 times, the stock is pricing in continued execution on capacity expansion, and any miss on volumes or margins could trigger a sharp correction, as the recent 12% pullback from the 52-week high already shows.
Being a small-cap counter, this specialty fats stock also carries liquidity and volatility risk, with daily traded volumes that can swing widely and make it harder to enter or exit large positions without moving the price. Raw material risk is real too, since shea nuts and mango kernels are agricultural commodities sourced from West Africa, exposing margins to crop yields, currency movements and geopolitical instability in sourcing regions such as Chad and Burkina Faso.
Customer concentration is another factor, since a large share of revenue comes from a relatively small set of global chocolate and cosmetics majors, so any change in sourcing strategy by even one large client could dent growth. Dividend payout is also minimal, with a yield of around 0.04%, so almost the entire return for shareholders in this specialty fats stock has come from price appreciation rather than income.
Download the Univest iOS App or Univest Android App to track the Manorama Industries share price live
Manorama Industries Share: Analyst View
Manorama Industries Share Price Target
No verified brokerage share price target for Manorama Industries is publicly available at this time, and that is not unusual for a specialty fats stock of this size, so this specialty fats stock is better assessed against its own price history and earnings trend. The stock’s 52-week high near Rs 2,150 and 52-week low near Rs 1,061 give a wide trading range, and the current price of roughly Rs 1,885 sits closer to the upper half of that band, suggesting the market has already priced in a fair amount of the recent earnings growth.
Until a named brokerage publishes a formal Manorama Industries share price target, investors tracking this specialty fats stock are likely to watch the pace of the Rs 460 crore capacity expansion, progress on the Chad and Burkina Faso sourcing projects, and whether margins can hold above 25% as volumes scale, since these are the levers that will decide whether the current valuation premium is justified.
Other Stocks to Track From the Same Return Screen
Beyond this specialty fats stock, a screen of NSE small-cap stocks ranked by recent returns also includes related names such as Amagi Media Labs with a 6-month return of 70.65%, Carborundum Universal at 70.50% and Sudarshan Chemical at 58.43%.
Among the names covered from that screen, MTAR Technologies returned 396.53% over one year. Readers can compare this specialty fats stock with the Nifty 50 benchmark and track each of these names on Univest before making any decision.
Conclusion
To sum up, this specialty fats stock has delivered a genuine, earnings-backed rally of approximately 49% in six months, powered by record quarterly revenue, expanding margins and a clear roadmap for fresh fractionation and refining capacity. The story is not without risk, given a rich valuation, small-cap liquidity and reliance on agricultural raw materials sourced from Africa, but the underlying business of supplying cocoa butter alternatives and shea-based ingredients to global chocolate and cosmetics majors continues to grow at a pace that has kept both the Manorama Industries share price and investor interest firmly in focus.
Disclaimer: Data and figures in this article are sourced from publicly available information and may or may not be accurate. Please verify all data independently before making any investment decision. Past returns do not guarantee future returns. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is a specialty fats stock and why is Manorama Industries called one?
Ans. A specialty fats stock refers to a company that manufactures engineered vegetable fats such as cocoa butter alternatives, cocoa butter equivalents and shea or mango butter-based ingredients used in chocolate, cosmetics and pharmaceutical products. Manorama Industries fits this description because it supplies these specialty fats to global majors including Ferrero, Mondelez, Mars, Hershey and Nestle across more than 39 countries.
How much has the Manorama Industries share price risen in six months?
Ans. The Manorama Industries share price rose approximately 49% between 24 March 2026 and 24 September 2026, moving from around Rs 1,265 to about Rs 1,885. The stock had touched a 52-week high near Rs 2,150 in September 2026 before correcting roughly 12% into the current level.
What is driving the rally in this specialty fats stock?
Ans. The rally is driven by record quarterly revenue of about Rs 420 crore in the June 2026 quarter, EBITDA margin expansion to roughly 26.3%, and a clear capacity expansion plan worth about Rs 460 crore. Growing exports, now around 60% of revenue, and new sourcing operations in Chad and Burkina Faso have also supported investor confidence.
Is there a verified Manorama Industries share price target from a brokerage?
Ans. No verified brokerage share price target for Manorama Industries is publicly available as of this article. Investors are instead tracking the stock’s 52-week trading range of roughly Rs 1,061 to Rs 2,150 along with its quarterly earnings trend to judge fair value.
Did Manorama Industries do a stock split or bonus issue recently?
Ans. No. Manorama Industries carried out a stock split, reducing face value from Rs 10 to Rs 2, back in March 2024, which is well outside the six-month window covered here. The 49% rise in the last six months reflects genuine price appreciation and is not a split or bonus artifact.
What is the promoter shareholding in Manorama Industries?
Ans. Promoter holding in Manorama Industries has stayed steady at approximately 54.3% through the first half of 2026, after declining gradually from levels above 57% in 2024. Institutional ownership, while still modest at a combined 5-6% between FIIs and DIIs, has been gradually increasing.
What are the main risks in this specialty fats stock?
Ans. The main risks include a rich valuation at nearly 47 times earnings against an industry average closer to 35 times, small-cap liquidity and volatility, and raw material exposure since shea nuts and mango kernels are sourced from West Africa. Customer concentration among a few large global chocolate and cosmetics buyers is an additional risk to watch.
Is Manorama Industries share price still worth watching after this rally?
Ans. The Manorama Industries share price remains worth tracking because the company’s revenue and margin growth are backed by real capacity additions and export demand rather than one-off factors. However, given the stock has already corrected about 12% from its recent high and trades at a premium valuation, investors should weigh the risks alongside the growth story before making a decision.
